Dr Reddy'S Laboratories Ltd Announced The Launch Of Febuxostat Tablets, A Therapeutic Equivalent Generic Version Of Uloric (Febuxostat) Tablets Approved By The Us Food And Drug Administration (Fda).The Uloric Brand And Generic Had Us Sales Of Approximately Us$ 108 Million Mat For The Most Recent Twelve Months Ending In October 2020, According To Iqvia Health.Dr Reddy'S Febuxostat Tablets Are Available In 40 Mg And 80 Mg Strengths In Bottle Count Sizes Of 30 Tablets
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!